Vaccine Development for Herpes Simplex Viruses: A Commentary of Special Issue Editors

Vaccines (Basel). 2021 Feb 16;9(2):158. doi: 10.3390/vaccines9020158.

Abstract

Herpes simplex virus type 1 and 2 (HSV1 and HSV2) are global, widespread human pathogens transmitted by direct contact that cause lifelong, recurrent asymptomatic and painful symptomatic clinical illnesses (cold sores, keratitis, blepharitis, meningitis, encephalitis, genital infections), overt disease and severe sequelae in neonatal and immune-compromised patients, and increased risk of cervical cancer and other sexually transmitted infections, including HIV [...].

Publication types

  • Editorial